ConductScience.org, home

Paper20047544

Single-dose azithromycin versus seven days of amoxycillin in the treatment of acute otitis media in Aboriginal children (AATAAC): a double blind, randomised controlled trial.

Morris PS and 6 others. Med J Aust, 2010. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Single-dose azithromycin versus seven days of amoxycillin in the treatment of acute otitis media in Aboriginal children (AATAAC): a double blind, randomised controlled trial. Papers, record 20047544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20047544

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Single-dose azithromycin versus seven days of amoxycillin in the treatment of acute otitis media in Aboriginal children (AATAAC): a double blind, randomised controlled trial.
PubMed
Journal
Med J Aust
PubMed
Year
2010
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2024-11-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morris PSPeter S
2Gadil GGaudencio
3McCallum GBGabrielle B
4Wilson CACate A
5Smith-Vaughan HCHeidi C
6Torzillo PPaul
7Leach AJAmanda J

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AmoxicillinMajor topic
Anti-Bacterial AgentsMajor topic
AzithromycinMajor topic
Otitis MediaMajor topic
Australia
Child
Child, Preschool
Confidence Intervals
Double-Blind Method
Female
Haemophilus influenzae
Humans
Infant
Male
Nose
Odds Ratio
Streptococcus pneumoniae
Tympanic Membrane Perforation

Source PubMed

Download CSV of topics

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42592875
Watchful Waiting Compared With Immediate Antibiotics for Urban Aboriginal and Torres Strait Islander Children With Uncomplicated Acute Otitis Media (WATCH): A Non-Inferiority Randomised Controlled Trial.
Med J Aust2026https://conductscience.org/library/papers/42592875PubMed
36967743Can non-typeable Haemophilus influenzae carriage surveillance data infer antimicrobial resistance associated with otitis media?Pediatr Investig2023https://conductscience.org/library/papers/36967743PubMed
36901001Exploring the Reported Strengths and Limitations of Aboriginal and Torres Strait Islander Health Research: A Narrative Review of Intervention Studies.Int J Environ Res Public Health2023https://conductscience.org/library/papers/36901001PubMed
35534039
Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trial.
BMJ Open Respir Res2022https://conductscience.org/library/papers/35534039PubMed
35498792
BIGDATA: A Protocol to Create and Extend a 25-Year Clinical Trial and Observational Data Asset to Address Key Knowledge Gaps in Otitis Media and Hearing Loss in Australian Aboriginal and Non-Aboriginal Children.
Front Pediatr2022https://conductscience.org/library/papers/35498792PubMed
33894769Efficacy and safety of azithromycin and amoxicillin/clavulanate for otitis media in children: a systematic review and meta-analysis of randomized controlled trials.Ann Clin Microbiol Antimicrob2021https://conductscience.org/library/papers/33894769PubMed
33641192Otitis media guidelines for Australian Aboriginal and Torres Strait Islander children: summary of recommendations.Med J Aust2021https://conductscience.org/library/papers/33641192PubMed
30396360The unsolved problem of otitis media in indigenous populations: a systematic review of upper respiratory and middle ear microbiology in indigenous children with otitis media.Microbiome2018https://conductscience.org/library/papers/30396360PubMed
29265639Defining lower airway bacterial infection in children with chronic endobronchial disorders.Pediatr Pulmonol2018https://conductscience.org/library/papers/29265639PubMed
28702292Geographic consistency in dominant, non-typeable Haemophilus influenzae genotypes colonising four distinct Australian paediatric groups: a cohort study.Pneumonia (Nathan)2016https://conductscience.org/library/papers/28702292PubMed
28702289Macrolide resistance in pneumococci-is it relevant?Pneumonia (Nathan)2016https://conductscience.org/library/papers/28702289PubMed
26363637Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.Eur J Clin Microbiol Infect Dis2015https://conductscience.org/library/papers/26363637PubMed
25749735Azithromycin for acute lower respiratory tract infections.Cochrane Database Syst Rev2015https://conductscience.org/library/papers/25749735PubMed
25109288Otitis media in children vaccinated during consecutive 7-valent or 10-valent pneumococcal conjugate vaccination schedules.BMC Pediatr2014https://conductscience.org/library/papers/25109288PubMed
24285816Absence of an important vaccine and diagnostic target in carriage- and disease-related nontypeable Haemophilus influenzae.Clin Vaccine Immunol2014https://conductscience.org/library/papers/24285816PubMed
24099576Dominance of Haemophilus influenzae in ear discharge from Indigenous Australian children with acute otitis media with tympanic membrane perforation.BMC Ear Nose Throat Disord2013https://conductscience.org/library/papers/24099576PubMed
23940582Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasis.PLoS One2013https://conductscience.org/library/papers/23940582PubMed
23421781Bronchiectasis exacerbation study on azithromycin and amoxycillin-clavulanate for respiratory exacerbations in children (BEST-2): study protocol for a randomized controlled trial.Trials2013https://conductscience.org/library/papers/23421781PubMed
23033913Quantitative PCR of ear discharge from Indigenous Australian children with acute otitis media with perforation supports a role for Alloiococcus otitidis as a secondary pathogen.BMC Ear Nose Throat Disord2012https://conductscience.org/library/papers/23033913PubMed
21649905Viral-bacterial co-infection in Australian Indigenous children with acute otitis media.BMC Infect Dis2011https://conductscience.org/library/papers/21649905PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20047544

GET https://conductscience.org/api/papers/v1/20047544/cited_by?page=2